Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00280-015-2698-7
Published Online: 2015-02-13
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Joerger, M.
Huitema, A. D. R.
Boot, H.
Cats, A.
Doodeman, V. D.
Smits, P. H. M.
Vainchtein, L.
Rosing, H.
Meijerman, I.
Zueger, M.
Meulendijks, D.
Cerny, T. D.
Beijnen, J. H.
Schellens, J. H. M.
Text and Data Mining valid from 2015-02-13